Lung Cancer Support Group Information Card

Ali Burgin, Advanced Pharmacist at Royal Surrey NHS Foundation Trust (RSCH), has worked with ALK Positive UK charity to design a credit card sized information card containing the specific lung cancer mutation patient support group details.  The card will be given out by pharmacists to patients at RSCH when they receive their first cycle of oral tyrosine kinase inhibitor medication.

 

If any other organisation would like to give this card to their patients please contact Debra Montague (chair of the Oncogene-  Driven Lung Cancer Patient Alliance) via email at [email protected] to receive printed copies (maximum 25 cards per order). Please include the name and full address of the person to receive these cards in the email.

Latest News

By BOPA Executive Committee on 15th July 2025

BSH Membership Survey 2025 – Pharmacy input required!

BOPA Members, As part of our ongoing  and increased collaborations with the British Society of Haematology (BSH) we would like to circulate the BSH Membership Survey 2025.  BSH are seeking…

Read article
By BOPA Immunotherapy Specialist Advisory Group on 14th July 2025

IOCN and UKSACT Board joint letter to NHSE

Hello All One of the pressing issues the BOPA Immunotherapy Specialist Advisory Group has been working over the past year, is addressing/improving the access to second line immunosuppressants for the…

Read article
By BOPA Committee on 14th July 2025

2025 Elections to the BOPA Executive Committee: Call for nomination of members

BOPA is looking for new Executive Committee members who are dedicated to furthering the association’s aims and who are willing, and able, to spend time helping run the organisation. Those…

Read article
By BOPA committee on 10th July 2025

Update to BOPA Standards – New Guidance on Pharmacy Technician SACT Verification (Section 3.3)

Dear BOPA Members, We are pleased to share an important update to the BOPA Standards for the Pharmacy Verification of Prescriptions for Cancer Medicines (Version 5.0, 3 June 2025). A…

Read article